Modular Medical submits next-gen insulin pump for FDA clearance

$ 27.50

5 (785) In stock

Modular Medical (Nasdaq:MODD) announced today that it submitted its next-generation MODD1 insulin pump to the FDA for 510(k) clearance.

A Guide to Insulin Pumps and New Diabetes Technology

Procept BioRobotics wins de novo nod from FDA for Aquabeam prostate treatment - MassDevice

David Kliff on LinkedIn: “Industry First” Watch With Blood Sugar Monitor Announced By Huawei

Why people with type 1 diabetes should (not) avoid these Top 10 AID Systems

DarioHealth wins FDA nod for Android diabetes app - MassDevice

BrainScope wins FDA nod for Ahead 300 TBI scanner - MassDevice

FDA clears Koya Medical's active compression therapy on the go - MassDevice

David Kliff on LinkedIn: Modular Medical submits next-gen insulin pump for FDA clearance

Olympus updates reprocessing instructions for Duodenoscopes - MassDevice

Welldoc says CGM, digital health combo offers better glycemic outcomes

Drug Delivery Business News di LinkedIn: Embecta stock slides before hours on mixed Q4 results

Drug Delivery Business News on LinkedIn: 8 drug delivery innovations you should know

Related products

Medtronic launches insulin pump system for Type 1 diabetes

What is an Insulin Pump?

Insulin Pump Systems Medtronic Diabetes for Healthcare Professionals

Study looks at Achilles' heel of insulin pump technology - UW Medicine

t:slim X2 Insulin Pump, Type 1 Diabetes Insulin Pump